Analysis of mutations and recombination activity in RAG-deficient patients
- PMID: 21131235
- DOI: 10.1016/j.clim.2010.11.005
Analysis of mutations and recombination activity in RAG-deficient patients
Abstract
Mutations in the recombination activating genes (RAG1 or RAG2) can lead to a variety of immunodeficiencies. Herein, we report 5 cases of RAG deficiency from 5 families: 3 of Omenn syndrome, 1 of severe combined immunodeficiency, and 1 of combined immunodeficiency with oligoclonal TCRγδ(+) T cells, autoimmunity and cytomegalovirus infection. The genetic defects were heterogeneous and included 6 novel RAG mutations. All missense mutations except for Met443Ile in RAG2 were located in active core regions of RAG1 or RAG2. V(D)J recombination activity of each mutant was variable, ranging from half of the wild type activity to none, however, a significant decrease in average recombination activity was demonstrated in each patient. The reduced recombination activity of Met443Ile in RAG2 may suggest a crucial role of the non-core region of RAG2 in V(D)J recombination. These findings suggest that functional evaluation together with molecular analysis contributes to our broader understanding of RAG deficiency.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.Clin Genet. 2004 Apr;65(4):322-6. doi: 10.1111/j.1399-0004.2004.00227.x. Clin Genet. 2004. PMID: 15025726
-
More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.Clin Immunol. 2010 May;135(2):183-92. doi: 10.1016/j.clim.2010.01.013. Epub 2010 Feb 20. Clin Immunol. 2010. PMID: 20172764 Review.
-
Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.Clin Immunol. 2005 Apr;115(1):70-3. doi: 10.1016/j.clim.2004.08.016. Clin Immunol. 2005. PMID: 15870023
-
Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.Clin Immunol. 2015 Jun;158(2):167-73. doi: 10.1016/j.clim.2015.04.003. Epub 2015 Apr 11. Clin Immunol. 2015. PMID: 25869295
-
Human RAG mutations: biochemistry and clinical implications.Nat Rev Immunol. 2016 Apr;16(4):234-46. doi: 10.1038/nri.2016.28. Epub 2016 Mar 21. Nat Rev Immunol. 2016. PMID: 26996199 Free PMC article. Review.
Cited by
-
RAG1 deficiency may present clinically as selective IgA deficiency.J Clin Immunol. 2015 Apr;35(3):280-8. doi: 10.1007/s10875-015-0146-4. Epub 2015 Mar 6. J Clin Immunol. 2015. PMID: 25739914
-
Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection.J Clin Immunol. 2015 Nov;35(8):754-60. doi: 10.1007/s10875-015-0207-8. Epub 2015 Oct 29. J Clin Immunol. 2015. PMID: 26515615 Free PMC article.
-
Evolutionary preservation of CpG dinucleotides in RAG1 may elucidate the relatively high rate of methylation-mediated mutagenesis of RAG1 transposase.Immunol Res. 2024 Jun;72(3):438-449. doi: 10.1007/s12026-023-09451-8. Epub 2024 Jan 19. Immunol Res. 2024. PMID: 38240953 Free PMC article.
-
Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.Clin Exp Immunol. 2019 Feb;195(2):202-212. doi: 10.1111/cei.13222. Epub 2018 Nov 4. Clin Exp Immunol. 2019. PMID: 30307608 Free PMC article.
-
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic-derived T-cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency.Pediatr Blood Cancer. 2023 May;70(5):e30183. doi: 10.1002/pbc.30183. Epub 2022 Dec 30. Pediatr Blood Cancer. 2023. PMID: 36583469 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources